- Home
- KLRS vs BVFL Comparison
KLRS vs BVFL Comparison
Compare KLRS & BVFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- BVFL
- Stock Information
- Founded
- KLRS 2019
- BVFL 1873
- Country
- KLRS United States
- BVFL United States
- Employees
- KLRS N/A
- BVFL N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- BVFL Savings Institutions
- Sector
- KLRS Health Care
- BVFL Finance
- Exchange
- KLRS Nasdaq
- BVFL Nasdaq
- Market Cap
- KLRS 129.0M
- BVFL 150.2M
- IPO Year
- KLRS N/A
- BVFL N/A
- Fundamental
- Price
- KLRS $2.61
- BVFL $15.63
- Analyst Decision
- KLRS Buy
- BVFL
- Analyst Count
- KLRS 1
- BVFL 0
- Target Price
- KLRS N/A
- BVFL N/A
- AVG Volume (30 Days)
- KLRS 38.9K
- BVFL 101.9K
- Earning Date
- KLRS 08-15-2025
- BVFL 07-21-2025
- Dividend Yield
- KLRS N/A
- BVFL N/A
- EPS Growth
- KLRS N/A
- BVFL N/A
- EPS
- KLRS N/A
- BVFL 1.06
- Revenue
- KLRS N/A
- BVFL $38,257,000.00
- Revenue This Year
- KLRS N/A
- BVFL N/A
- Revenue Next Year
- KLRS N/A
- BVFL N/A
- P/E Ratio
- KLRS N/A
- BVFL $14.73
- Revenue Growth
- KLRS N/A
- BVFL 1.89
- 52 Week Low
- KLRS $2.28
- BVFL $12.50
- 52 Week High
- KLRS $24.15
- BVFL $18.19
- Technical
- Relative Strength Index (RSI)
- KLRS N/A
- BVFL 67.45
- Support Level
- KLRS N/A
- BVFL $15.83
- Resistance Level
- KLRS N/A
- BVFL $16.10
- Average True Range (ATR)
- KLRS 0.00
- BVFL 0.38
- MACD
- KLRS 0.00
- BVFL 0.12
- Stochastic Oscillator
- KLRS 0.00
- BVFL 86.98
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing therapeutics. Kalaris is developing TH103, a novel, clinical stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body native, highest affinity VEGF receptor 1.
About BVFL BV Financial Inc.
BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.